Forearm reactive hyperemia and mortality in end-stage renal disease

Kidney International

Volumn 65, Issue 2, 2004, Pages 700-704

  London, Gérard M ^a   Pannier, Bruno ^b   Agharazii, Mohsen ^b   Guerin, Alain P ^b   Verbeke, Francis H M ^b   Marchais, Sylvain J ^b  

^a Hopital Manhes   (France)

^b NONE

Author keywords

Endothelium; Kidney; Mortality; Vasodilation

Indexed keywords

ADULT; AGED; AORTA; ARTERY COMPLIANCE; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; FOREARM; HEMODIALYSIS; HUMAN; HYPEREMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PLETHYSMOGRAPHY; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; VASODILATATION;

EID: 1642561670     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00434.x     Document Type: Article

References (31)

1. AL SUWAIDI J, HAMASAKI S, HIGANO ST, et al: Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101:948-954, 2000
2. SCHÄCHINGER V, BRITTEN MB, ZEIHER AM: Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899-1906, 2000
3. PERTICONE F, CERAVALO R, PUJIA A, et al: Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104:191-196, 2001
4. HEITZER T, SCHLINZIG T, KROHN K, et al: Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104:2673-2678, 2001
5. HALCOX JPJ, SCHENKE WH, ZALOS G, et al: Prognostic value of coronary endothelial dysfunction. Circulation 106:653-658, 2002
6. RAIJ L: Nitric oxide in hypertension: relationship with renal injury and left ventricular hypertrophy. Hypertension 31:189-193, 1998
7. HAYAKAWA H, RAIJ L: The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension. Hypertension 29:235-241, 1997
8. GHIADONI L, TADDEI S, VIRDIS A, et al: Endothelial function and common carotid artery wall thickening in patients with essential hypertension. Hypertension 32:25-32, 1998
9. JOANNIDES R, BAKKALI EH, LE ROY F, et al: Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis. Nephrol Dial Transplant 12:2623-2628, 1997
10. PANNIER B, GUÉRIN AP, MARCHAIS SJ, et al: Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease. Kidney Int 57:1091-1099, 2000
11. SILBERBERG J, BARRE PE, PRICHARD SS, et al: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36:286-290, 1989
12. BLACHER J, GUÉRIN AP, PANNIER B, et al: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99:2434-2439, 1999
13. BENEDETTO FA, MALLAMACI F, TRIPEPI G, et al: Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol 12:2458-2464, 2001.
14. LONDON GM, BLACHER J, PANNIER B, et al: Arterial wave reflections and survival in end-stage renal failure. Hypertension 38:434-438, 2001
15. LONDON GM, PANNIER B, GUÉRIN AP, et al: Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease: Comparative effects of ACE inhibition and calcium channel blockade. Circulation 90:2786-2796, 1994
16. BONITHON-KOPP C, DUCIMETIÈRE P, TOUBOUL JP, et al: Plasma converting-enzyme activity and carotid wall thickening. Circulation 89:952-954, 1994
17. DEVEREUX RB, REICHER N: Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method. Circulation 55:613-618, 1977
18. ICHIMARU K, HORIE A: Microangiopathic changes of subepidermal capillaries in end-stage renal failure. Nephron 46:144-149, 1987
19. TAGAWA T, IMAIZUMI T, ENDO T, SHIRAMOTO M, et al: Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation 90:2556-2559, 1987
20. JOYNER MJ, DIETZ NM: Nitric oxide and vasodilation in human limbs. J Appl Physiol 83:1785-1796, 1997
21. JOANNIDES R, HAEFELI WE, LINDER LE, et al: Nitric oxide is responsible for flow-dependent dilation of human peripheral conduit arteries in vivo. Circulation 91:1314-1319, 1995
22. MEREDITH IT, CURRIE KE, ANDERSON TJ, et al: Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol 270:H1453-1440, 1996
23. VALLANCE P, LEONE A, CALVER A, et al: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572-575, 1992
24. ZOCCALI C, BODE-BOGER S, MALLAMACI F, et al: Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet 358:2113-2117, 2001
25. WEVER R, BOER P, HIJMERING M, et al: Nitric oxide production is reduced in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 19:1168-1172, 1999
26. GUÉRIN AP, BLACHER J, PANNIER B, et al: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103:987-992, 2001
27. FICHTLSCHERER S, ROSENBERGER G, WALTER DH, et al: Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 102:1000-1006, 2000
28. FOLEY RN, PARFREY PS, HARNETT JD, et al: Hypoalbuminemia, cardiac morbidity and mortality in end-stage renal disease. J Am Soc Nephrol 7:728-736, 1996
29. STENVINKEL P, HEIMBURGER O, PAULTRE F, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 51:1899-1911, 1999
30. ZIMMERMANN J, HERRLINGER S, PRUY A, et al: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648-655, 1999
31. ANDERSON TJ, UEHATA A, GERHARD MD, et al: Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26:1235-1241, 1995